国家胆固醇教育计划:进展和前景
1National Cholesterol Education Program, National Heart, Lung, and Blood Institute, Bethesda, MD 20892-2480, USA. cleemanj@gwgate.nhlbi.nih.gov
JAMA
|January 6, 1999
概括
国家胆固醇教育计划 (NCEP) 通过教育成功降低了高血胆固醇. 需要继续努力解决治疗不足的问题,特别是在冠心病 (CHD) 患者中.
科学领域:
- 心血管健康 心血管健康
- 公共卫生倡议 公共卫生倡议
- 翻译研究是翻译研究.
背景情况:
- 国家心脏,肺和血液研究所 (NHLBI) 已经催化了50年的研究翻译.
- 国家胆固醇教育计划 (NCEP) 是这一角色的典范,将研究转化为实践.
- NCEP的成功是建立在科学证据和组织伙伴关系的基础上.
研究的目的:
- 评估NCEP教育活动的影响.
- 评估降低高血胆固醇患病率的进展情况.
- 确定剩余的挑战和胆固醇管理的未来方向.
主要方法:
- 国家医疗健康计划为医疗保健专业人员和公众开展了教育活动.
- 通过观察胆固醇意识,饮食习惯,血清胆固醇水平和冠心病 (CHD) 死亡率的趋势来衡量程序性成功.
- 分析的重点是自1985年NCEP成立以来的时期.
主要成果:
- 在过去十年中,在降低高血胆固醇患病率方面取得了显著进展.
- 关键趋势包括增加胆固醇意识,减少饮食脂肪摄入量,降低血清胆固醇水平和降低心血管疾病死亡率.
- 尽管有进展,但胆固醇水平仍未得到充分治疗,特别是在患有心脏病的患者中.
结论:
- 据证明,NCEP改善了有关胆固醇管理的临床和公共卫生实践.
- 仍然存在重大的科学和教育挑战,需要持续努力.
- 未来的NCEP策略将利用新兴的科学来帮助CHD患者和初级预防.
相关概念视频
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...